Clinical trial
Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in…
NCT00181220 · Johns Hopkins University, Other · Withdrawn
Key facts
| NCT number | NCT00181220 |
|---|---|
| Title | Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma |
| Official title | Valproic Acid in the Induction of EBV Lytic Cycle Antigen Expression in Nasopharyngeal Carcinoma |
| Lead sponsor | Johns Hopkins University, Other |
| Collaborators | National University Hospital of Singapore |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Nasopharyngeal Carcinoma |
| Intervention type | Drug |
| Interventions | valproic acid |
| Enrollment | 0 |
| Start date | Apr 1, 2004 |
| Completion | Sep 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | May 18, 2020 |
| Countries | Singapore |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: